作者：
Shishi,Lin [1]
;
Sergei,Dikler [2]
;
William D,Blincoe [3]
;
Ronald D,Ferguson [1]
;
Robert P,Sheridan [4]
;
Zhengwei,Peng [4]
;
Donald V,Conway [5]
;
Kerstin,Zawatzky [3]
;
Heather,Wang [3]
;
Tim,Cernak [6]
;
Ian W,Davies [7]
;
Daniel A,DiRocco [7]
;
Huaming,Sheng [8]
;
Christopher J,Welch [8]
;
Spencer D,Dreher [9]
作者单位：
Chemistry Capabilities Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
[1]
Bruker Daltonics, Inc., Billerica, MA 01821, USA.
[2]
Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA.
[3]
Modeling and Informatics, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
[4]
Discovery Sample Management, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
[5]
Discovery Chemistry, Merck & Co., Inc., Boston, MA 02115 USA.
[6]
Process Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA.
[7]
Analytical Research and Development, Merck & Co., Inc., Rahway, NJ 07065, USA. huaming.sheng@merck.com christopher@welchinnovation.com spencer_dreher@merck.com.
[8]
Chemistry Capabilities Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, NJ 07033, USA. huaming.sheng@merck.com christopher@welchinnovation.com spencer_dreher@merck.com.
[9]
DOI
10.1126/science.aar6236
PMID
29794218
发布时间
2018-09-05
换一批
换一批
